by Mark Chiang

马克·蒋

Share To

分享到

Biovance Capital Partners, alongside OrbiMed and Torrey Pines, has led a Series A financing round for Mondego Bio, a Portuguese startup focused on developing innovative cancer treatments. The investment marks the first deployment of funds from Biovance Capital Fund I and signals significant backing for the Lisbon-based company’s efforts in advancing oncology therapeutics..

Biovance Capital Partners联合OrbiMed和Torrey Pines，领投了葡萄牙初创公司Mondego Bio的A轮融资，该公司专注于开发创新的癌症治疗方法。此次投资标志着Biovance Capital Fund I的首笔资金部署，同时也为这家位于里斯本的公司在推进肿瘤治疗方面提供了重要支持。

Mondego Bio was co-founded by the three participating investors and is working to create breakthrough solutions in cancer care. The financial details of the Series A funding have not been disclosed. This development positions Mondego Bio as a key player in Portugal’s growing biotech sector, with support from prominent venture capital firms specializing in life sciences..

Mondego Bio 由三位参与投资的创始人共同创立，致力于在癌症治疗领域创造突破性解决方案。A 轮融资的财务细节尚未披露。这一进展使 Mondego Bio 成为葡萄牙不断发展的生物技术领域的重要参与者，并得到了专注于生命科学的知名风险投资公司的支持。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源：GO-AI-ne1

Date: September 18, 2025

日期：2025年9月18日

Related posts:

相关帖子：

Generic Drug Market to Reach $1.3 Trillion by 2028 Amidst Rising Demand and Regulatory Shifts

仿制药市场将在需求增长和监管变革中于2028年达到1.3万亿美元

Daiichi Sankyo CEO Hiroyuki Okuzawa to Lead Expansion of ADC Portfolio Including Enhertu and Datroway

第一三共CEO奥泽宏幸将领导包括Enhertu和Datroway在内的ADC产品组合的扩展。

Infliximab Biosimilars Account for 42 Percent of Pediatric IBD Treatments by 2023

到2023年，英夫利昔单抗生物类似药占儿科IBD治疗的42%。

Study Links Consuming Five Artificially Sweetened Beverages Weekly to 6 Percent Higher Gestational Diabetes Risk

研究发现，每周饮用五份人工甜味饮料与妊娠糖尿病风险增加6%有关

©www.geneonline.com All rights reserved. Collaborate with us:

©www.geneonline.com 版权所有。与我们合作：

[email protected]

[email protected]

Author

作者

Mark Chiang

马克·蒋

Related Post

相关内容

News Flash

新闻快讯

South Korea Aims to Double Biopharmaceutical Exports by 2030

韩国计划到2030年将生物制药出口翻一番

2025-09-18

2025年9月18日